Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to $123.8 million.

  • Organogenesis Holdings' Total Liabilities fell 2617.06% to $123.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.8 million, marking a year-over-year decrease of 2617.06%. This contributed to the annual value of $112.6 million for FY2024, which is 3793.08% down from last year.
  • As of Q3 2025, Organogenesis Holdings' Total Liabilities stood at $123.8 million, which was down 2617.06% from $99.9 million recorded in Q2 2025.
  • Organogenesis Holdings' Total Liabilities' 5-year high stood at $202.0 million during Q2 2022, with a 5-year trough of $99.3 million in Q1 2025.
  • For the 5-year period, Organogenesis Holdings' Total Liabilities averaged around $168.2 million, with its median value being $180.5 million (2024).
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 3605.82% in 2021, then plummeted by 4495.74% in 2025.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Total Liabilities stood at $201.9 million in 2021, then fell by 9.03% to $183.7 million in 2022, then dropped by 1.27% to $181.4 million in 2023, then plummeted by 37.93% to $112.6 million in 2024, then increased by 10.02% to $123.8 million in 2025.
  • Its Total Liabilities stands at $123.8 million for Q3 2025, versus $99.9 million for Q2 2025 and $99.3 million for Q1 2025.